Citations (125)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Michele Staton, Martha Tillson, Mary M Levi, Megan Dickson, Matt Webster & Carl Leukefeld. (2023) Identifying and Treating Incarcerated Women Experiencing Substance Use Disorders: A Review. Substance Abuse and Rehabilitation 14, pages 131-145.
Read now
Read now
Christopher Cambron & Jason Castillo. (2023) Closing the gap in substance use disorder treatment through paraprofessional counselor training. Journal of Social Work Practice in the Addictions 23:4, pages 289-303.
Read now
Read now
Michele Staton, Erika Pike, Mary Levi & Michelle Lofwall. (2023) The Importance of Justice and Health Care Partnerships in MOUD Feasibility Trials. Journal of Social Work Practice in the Addictions 0:0, pages 1-15.
Read now
Read now
Duaa Fatima, Willis H. Tsai, Jennifer Corrigan, Imhokhai Ogah, Ada Ip-Buting, Heather Sharpe, Cheryl R. Laratta, Peter Peller & Sachin R. Pendharkar. (2023) Exploring patient-borne costs and wait times for obstructive sleep apnea (OSA) care among rural and urban adults. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 7:1, pages 21-27.
Read now
Read now
Michael J. Broman, Emily Pasman, Suzanne Brown, Jamey J. Lister, Elizabeth Agius & Stella M. Resko. (2023) Social support is associated with reduced stigma and shame in a sample of rural and small urban adults in methadone treatment. Addiction Research & Theory 31:1, pages 37-44.
Read now
Read now
Emily Pasman, Guijin Lee, Rachel Kollin, Michael J. Broman, Elizabeth Aguis & Stella M. Resko. (2022) Emotional exhaustion and workplace belongingness among peer recovery coaches during COVID-19. Journal of Social Work Practice in the Addictions 0:0, pages 1-13.
Read now
Read now
Kristine Ramsay-Seaner, Amber Letcher, Meagan Scott Hoffman, Emily Anderson & Charlotte Heckmann. (2022) Perceptions of prescription opioid use among rural farming and ranching communities: Preliminary implications for outreach and treatment. Substance Abuse 43:1, pages 1245-1250.
Read now
Read now
Brendan Saloner, Rachel K. Landis, Ritujith Jayakrishnan, Bradley D. Stein & Colleen L. Barry. (2022) A bridge too far? Distance to waivered physicians and utilization of buprenorphine treatment for opioid use disorder in West Virginia Medicaid. Substance Abuse 43:1, pages 682-690.
Read now
Read now
James B. Anderson, Stephen A. Martin, Anne Gadomski, Nicole Krupa, Daniel Mullin, Amber Cahill & Paul Jenkins. (2022) Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes. Substance Abuse 43:1, pages 222-230.
Read now
Read now
Emily Pasman, Guijin Lee, Rachel Kollin, Brooke Rodriguez, Elizabeth Agius, Erin Fanning Madden & Stella M. Resko. (2022) Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers. Substance Use & Misuse 57:12, pages 1828-1836.
Read now
Read now
Jennifer D. Ellis, Emily Pasman, Suzanne Brown, Jamey J. Lister, Elizabeth Agius & Stella M. Resko. (2022) An examination of correlates of simultaneous opioid and benzodiazepine use among patients in medication treatment for opioid use disorder in a small midwestern community. Journal of Addictive Diseases 40:4, pages 542-551.
Read now
Read now
Robin A. Thompson, David Johnson, Amber L. Kizewski, Lori Baier, Karen Coburn, Jennifer White, Terry Bunn & Ernest L. Fletcher. (2022) Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot. Journal of Addictive Diseases 40:4, pages 518-526.
Read now
Read now
Jodie C. Gary, Nancy R. Downing & Alison Pittman. (2022) The Impact of Parental Opioid Use Disorder on Children in Rural Texas. Substance Use & Misuse 57:8, pages 1273-1280.
Read now
Read now
Jina Sang, Rikki A. Patton & Insun Park. (2022) Comparing Perceptions of Addiction Treatment between Professionals and Individuals in Recovery. Substance Use & Misuse 57:6, pages 983-994.
Read now
Read now
Amanda M. Bunting, Megan Dickson & Michele Staton. (2022) Polysubstance use and re-incarceration in the 12-months after release from jail: a latent transition analysis of rural Appalachian women. The American Journal of Drug and Alcohol Abuse 48:3, pages 356-366.
Read now
Read now
Krista L. Scorsone, Emily A. Haozous, Leslie Hayes & Kim J. Cox. (2021) Ending the Chase: Experiences of Rural Individuals with Opioid Use Disorder. Substance Use & Misuse 56:8, pages 1224-1231.
Read now
Read now
Sierra Thomas, Alexa Singer & Albert Kopak. Receptivity to Jail-based medication for opioid use disorder among rural detention Administrators. Corrections 0:0, pages 1-19.
Read now
Read now
Articles from other publishers (108)
Jerel M. Ezell, Mai T. Pho, Babatunde P. Ajayi, Elinor Simek, Netra Shetty, Dawn A. Goddard‐Eckrich & Ricky N. Bluthenthal. (2024) Opioid use, prescribing and fatal overdose patterns among racial/ethnic minorities in the United States: A scoping review and conceptual risk environment model. Drug and Alcohol Review.
Crossref
Crossref
R. J. Fredericksen, R. Baker, A. Sibley, A. T. Estadt, D. Colston, L. S. Mixson, S. Walters, J. Bresett, X. A. Levander, G. Leichtling, T. Davy-Mendez, M. Powell, T. J. Stopka, M. Pho, J. Feinberg, J. Ezell, W. Zule, D. Seal, H. L. F. Cooper, B. M. Whitney, J. A. C. Delaney, H. M. Crane & J. I. Tsui. (2024) Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry. Harm Reduction Journal 21:1.
Crossref
Crossref
Keith R. Chichester, Grant Drawve, Michelle Sisson, Alejandro Giménez-Santana, Brandi McCleskey, Burel R. Goodin, Sylvie Mrug, Jeffery T. Walker & Karen L. Cropsey. (2023) Crime and Features of the Built Environment Predicting Risk of Fatal Overdose: A Comparison of Rural and Urban Ohio Counties with Risk Terrain Modeling. American Journal of Criminal Justice 49:2, pages 230-254.
Crossref
Crossref
Holly Mathias, Lois A. Jackson, Jane A. Buxton, Anik Dubé, Niki Kiepek, Fiona Martin & Paula Martin. (2024) What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada. Substance Abuse Treatment, Prevention, and Policy 19:1.
Crossref
Crossref
Cheyenne Fenstemaker, Elizabeth A. Abrams, Benjamin Obringer, Katherine King, Lindsay Y. Dhanani & Berkeley Franz. (2024) Primary care professionals’ perspectives on tailoring buprenorphine training for rural practice. The Journal of Rural Health.
Crossref
Crossref
Eli Raver, Sheldon M. Retchin, Yiting Li, Andrew D. Carlo & Wendy Y. Xu. (2024)
Rural–urban
differences in
out‐of‐network
treatment initiation and engagement rates for substance use disorders
. Health Services Research.
Crossref
Crossref
Melissa N. Poulsen, Sophie A. Roe, Patrick B. Asdell, Alanna Kulchak Rahm & Wade Berrettini. (2024) Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study. Journal of Substance Use and Addiction Treatment 158, pages 209250.
Crossref
Crossref
Sarah Oerther & Michelle M. Papachrisanthou. (2023) Ways parental health and stress shape the parenting of preteens in the rural Ozark Mountains. Family Relations 73:1, pages 171-192.
Crossref
Crossref
Jeffersson Santos, Amanda Acevedo-Morales, Lillian Jones, Tara Bautista, Carolyn Camplain, Chesleigh N. Keene & Julie Baldwin. (2023) Client perspectives on primary care integration in a rural-serving behavioral health center. Journal of Integrated Care 32:1, pages 31-44.
Crossref
Crossref
Lucas Böttcher, Tom Chou & Maria R D’Orsogna. (2024) Forecasting drug-overdose mortality by age in the United States at the national and county levels. PNAS Nexus 3:2.
Crossref
Crossref
José M. Flores, Emily Kan, Larissa J. Mooney, Huyen Pham, Yuhui Zhu, Kate Wolitzky-Taylor & Yih-Ing Hser. (2024) Medications for Opioid Use Disorder Among Transition Age Youth Compared to Adults 26 or Older in Rural Settings. JAACAP Open.
Crossref
Crossref
Patricia LiuP. Todd Korthuis & Bradley M. Buchheit. (2024) Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders. Annual Review of Medicine 75:1, pages 83-97.
Crossref
Crossref
Yih‐Ing Hser, Yuhui Zhu, Laura‐Mae Baldwin, Larissa J. Mooney & Andrew J. Saxon. (2023) Medication treatment for opioid use disorder among rural primary care patients. The Journal of Rural Health 40:1, pages 195-199.
Crossref
Crossref
Berkeley Franz, Lindsay Y. Dhanani, O. Trent Hall, Daniel L. Brook, Janet E. Simon & William C. Miller. (2023) Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US. Harm Reduction Journal 20:1.
Crossref
Crossref
Virginia Brown, Maria Bowie, Diane Bales, Anna Scheyett, Rebecca Thomas & Georgeanna Cook. (2023) Cooperative Extension offices as mental health hubs: A social ecological case study in rural Georgia, United States. SSM - Mental Health 3, pages 100191.
Crossref
Crossref
Aaron R. Brown, Jayme E. Walters, Beth Harmer, Lara Cates & Aubrey E. Jones. (2023) Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences. Journal of Substance Use and Addiction Treatment 155, pages 209153.
Crossref
Crossref
Alissa Davis, Kristi Lynn Stringer, Mari-Lynn Drainoni, Carrie B. Oser, Hannah K. Knudsen, Alison Aldrich, Hilary L. Surratt, Daniel M. Walker, Louisa Gilbert, Dget L. Downey, Sam D. Gardner, Sylvia Tan, Lisa M. Lines, Nathan Vandergrift, Nicole Mack, JaNae Holloway, Karsten Lunze, Ann Scheck McAlearney, Timothy R. Huerta, Dawn A. Goddard-Eckrich & Nabila El-Bassel. (2023) Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study. International Journal of Drug Policy 122, pages 104241.
Crossref
Crossref
Olivia K. Golan, Flora Sheng, Andrew W. Dick, Mark Sorbero, Daniel J. Whitaker, Barbara Andraka-Christou, Therese Pigott, Adam J. Gordon & Bradley D. Stein. (2023) Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018. Drug and Alcohol Dependence Reports 9, pages 100193.
Crossref
Crossref
Saeed Ahmed, Zeeshan Faruqui, Karuna Poddar, Siddhi Bhivandkar & Joji Suzuki. (2023) Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions. Journal of Opioid Management 19:5, pages 455-460.
Crossref
Crossref
Zora Kesich, Umedjon Ibragimov, Kelli Komro, Kenneth Lane, Melvin Livingston, April Young & Hannah L. F. Cooper. (2023) “I’m not going to lay back and watch somebody die”: a qualitative study of how people who use drugs’ naloxone experiences are shaped by rural risk environment and overdose education/naloxone distribution intervention. Harm Reduction Journal 20:1.
Crossref
Crossref
Nora C. Bridges, Rachel Taber, Abigail L. Foulds, Todd M. Bear, Renee M. Cloutier, Brianna L. McDonough, Adam J. Gordon, Gerald T. Cochran, Julie M. Donohue, Dale Adair, Ellen DiDomenico, Janice L. Pringle, Walid F. Gellad, David Kelley & Evan S. Cole. (2023) Medications for opioid use disorder in rural primary care practices: Patient and provider experiences. Journal of Substance Use and Addiction Treatment 154, pages 209133.
Crossref
Crossref
Chenglin Hong, Jordan Hoskin, Lorree K. Berteau, Jay T. Schamel, Elizabeth S. C. Wu, Adrian R. King, Laura A. Randall, Ian W. Holloway & Paula M. Frew. (2023) Violence Victimization, Homelessness, and Severe Mental Illness Among People Who Use Opioids in Three U.S. Cities. Journal of Interpersonal Violence 38:19-20, pages 11165-11185.
Crossref
Crossref
Li-Tzy Wu, Paolo Mannelli, William S. John, Alyssa Anderson & Robert P. Schwartz. (2023) Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff. Substance Abuse Treatment, Prevention, and Policy 18:1.
Crossref
Crossref
Yih‐Ing Hser, Larissa J. Mooney, Laura‐Mae Baldwin, Allison Ober, Lisa A. Marsch, Seth Sherman, Abigail Matthews, Sarah Clingan, Zhe Fei, Yuhui Zhu, Alex Dopp, Megan E. Curtis, Katie P. Osterhage, Emily G. Hichborn, Chunqing Lin, Megan Black, Stacy Calhoun, Caleb C. Holtzer, Noah Nesin, Denise Bouchard, Maja Ledgerwood, Margaret A. Gehring, Yanping Liu, Neul Ah Ha, Sean M. Murphy, Maria Hanano & Andrew J. Saxon. (2023) Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single‐arm, multisite feasibility study. The Journal of Rural Health 39:4, pages 780-788.
Crossref
Crossref
Amelia Bailey, Rithika Senthilkumar & Elizabeth A. Evans. (2023) Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail. Journal of Addiction Medicine 17:5, pages 568-573.
Crossref
Crossref
Trevor Magee, Caleb Peters, Samuel M. Jacobsen, Danya Nees, Bryan Dunford, Alicia Ito Ford & Matt Vassar. (2023) Inequities in the treatment of opioid use disorder: A scoping review. Journal of Substance Use and Addiction Treatment 152, pages 209082.
Crossref
Crossref
Anna Conway, Noa Krawczyk, Frances McGaffey, Sheri Doyle, Vanessa Baaklini, Alison D. Marshall, Carla Treloar, Corey S. Davis, Samantha Colledge-Frisby, Jason Grebely & Magdalena Cerdá. (2023) Typology of laws restricting access to methadone treatment in the United States: A latent class analysis. International Journal of Drug Policy 119, pages 104141.
Crossref
Crossref
Li-Tzy Wu, William S. John, Paolo Mannelli, Eric D. Morse, Alyssa Anderson & Robert P. Schwartz. (2023) Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.. Addiction Science & Clinical Practice 18:1.
Crossref
Crossref
Christopher Cambron & Jason Castillo. (2023) Closing the gap in substance use disorder treatment through paraprofessional counselor training. Journal of Social Work Practice in the Addictions, pages 1-15.
Crossref
Crossref
Arthur Robin Williams, Christopher Rowe, Ryan Gallagher, Shoshana V. Aronowitz, Jon Diamond-Reivich, & Adam Bisaga. (2023) Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder. JAMA Health Forum 4:7, pages e232247.
Crossref
Crossref
David L. Albright, Zainab Suntai, Justin T. McDaniel, Karen Johnson, Harvey Henson, Ellen Robertson & Shanna McIntosh. (2023) Opioid Use Disorder Among the Economically Disadvantaged in the Rural South. Journal of Addiction Medicine 17:4, pages 418-423.
Crossref
Crossref
Shikhar Shrestha, Megan R. Lindstrom, Daniel Harris, Peter Rock, Sumeeta Srinivasan, Jennifer C. Pustz, Ric Bayly & Thomas J. Stopka. (2023) Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky. Journal of Substance Use and Addiction Treatment 150, pages 209077.
Crossref
Crossref
Alison Smith Mitchell. (2023) Connecting the Dots: Understanding Biopsychosocial Factors Influencing Opioid Use Treatment Outcomes for Rural Adults. Families in Society: The Journal of Contemporary Social Services.
Crossref
Crossref
Lisa M. McFadden. (2023) Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic. Drug and Alcohol Dependence Reports 7, pages 100155.
Crossref
Crossref
Grant Victor, Bethany J. Hedden-Clayton, Jamey Lister, Guijin Lee, Philip Huynh & Bradley Ray. (2023) Community overdose surveillance: Fentanyl involvement in overdose deaths in rural Michigan. Drug and Alcohol Dependence Reports 7, pages 100150.
Crossref
Crossref
Jagpreet Chhatwal, Peter P. Mueller, Qiushi Chen, Neeti Kulkarni, Madeline Adee, Gary Zarkin, Marc R. LaRochelle, Amy B. Knudsen & Carolina Barbosa. (2023) Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States. JAMA Network Open 6:6, pages e2314925.
Crossref
Crossref
Cheryl L. Eschbach, Bengt B. Arnetz & Judith E. Arnetz. (2023) Designing and Evaluating Opioid Misuse Prevention Training for Rural Communities and Health Care Providers. Health Promotion Practice, pages 152483992311749.
Crossref
Crossref
Whitney Bremer, Karma Plaisance, Drew Walker, Matthew Bonn, Jennifer S. Love, Jeanmarie Perrone & Abeed Sarker. (2023) Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature. Frontiers in Public Health 11.
Crossref
Crossref
Amandeep Kaur & Karen S Williams. (2023) Improving Access to Harm Reduction Services in People Who Inject Drugs at a Rural Health System. The Guthrie Journal 75:1, pages 39-44.
Crossref
Crossref
Melissa N. Poulsen, William Santoro, Roseanne Scotti, Catherine Henderson, Meaghan Ruddy & Angela Colistra. (2023) Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19. Journal of Addiction Medicine 17:2, pages e110-e118.
Crossref
Crossref
Alexis Carl, Emily Pasman, Michael J. Broman, Jamey J. Lister, Elizabeth Agius & Stella M. Resko. (2023) Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone. Drug and Alcohol Dependence Reports 6, pages 100138.
Crossref
Crossref
R. R. Cook, C. Foot, O. A. Arah, K. Humphreys, K. E. Rudolph, S. X. Luo, J. I. Tsui, X. A. Levander & P. T. Korthuis. (2023) Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations. Addiction Science & Clinical Practice 18:1.
Crossref
Crossref
Tanner Bommersbach, Marissa Justen, Amanda M. Bunting, Melissa C. Funaro, Erin L. Winstanley & Paul J. Joudrey. (2023) Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review. International Journal of Drug Policy 112, pages 103931.
Crossref
Crossref
Christopher Cambron, Ramkiran Gouripeddi & Julio C. Facelli. (2023) Healthcare Provider Reports on Social Determinants of Health in Opioid Treatment. Psych 5:1, pages 60-69.
Crossref
Crossref
Priyanka Bansal, Bhavneesh Saini, Pir D. Bansal, Arun Bansal, Jaskanwar S. Dhillon, Vanipreet Kaur, Gulmohar Singh & Sumit Saini. (2023) Presenting Pattern and Psychiatric Comorbidities in Rural versus Urban Substance Dependent Patients: A Hospital-Based Cross-Sectional Study. Indian Journal of Community Medicine 48:5, pages 666-675.
Crossref
Crossref
Annabelle M. Belcher, Brook Kearley, Nathan Kruis, Nicholas Rowland, Natalie Spicyn, Thomas O. Cole, Christopher Welsh, Heather Fitzsimons, Katherine McLean & Eric Weintraub. (2023) Correlates of Staff Acceptability of a Novel Telemedicine-Delivered Medications for Opioid Use Disorder Program in a Rural Detention Center. SSRN Electronic Journal.
Crossref
Crossref
Miriam J. Landsman & Denise Rathman. (2022) Rural Challenges in Social Work Regulation. Research on Social Work Practice 33:1, pages 121-131.
Crossref
Crossref
David Tyler Coyle, Stephanie Stewart, Cole Bortz, Jane Manalo, Alexis Ritvo & Martin Krsak. (2023) Buprenorphine Prescribing and Dosing Limits: Evidence and Policy Goals. Substance Abuse 44:1-2, pages 17-23.
Crossref
Crossref
Jamey J. Lister & Paul J. Joudrey. (2022) Rural mistrust of public health interventions in the United States: A call for taking the long view to improve adoption. The Journal of Rural Health 39:1, pages 18-20.
Crossref
Crossref
Feitong Lei, Michelle R. Lofwall, Patricia R. Freeman, Emily Slade, Rachel Vickers‐Smith & Svetla Slavova. (2022) Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID‐19 pandemic in Kentucky. The Journal of Rural Health 39:1, pages 186-196.
Crossref
Crossref
Erin E. Miller, Jennifer Ball, Mary Emery, Christopher B. Robbins, Jeremy Daniel, Patricia Ahmed & Aaron Hunt. (2023) Promoting harm reduction in rural South Dakota using an interdisciplinary consortium. Journal of the American Pharmacists Association 63:1, pages 366-373.
Crossref
Crossref
Brian King, Louisa M. Holmes, Andrea Rishworth & Ruchi Patel. (2023) Geographic variations in opioid overdose patterns in Pennsylvania during the COVID-19 pandemic. Health & Place 79, pages 102938.
Crossref
Crossref
Michael H. Baca-Atlas, Stefani N. Baca-Atlas & Kelly Bossenbroek Fedoriw. 2023. Chronic Illness Care. Chronic Illness Care
71
84
.
Treah Haggerty, Nicholas A. Turiano, Tyra Turner, Patricia Dekeseredy & Cara L. Sedney. (2022) Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Geoff Bardwell, Manal Mansoor, Ashley Van Zwietering, Ellery Cleveland, Dan Snell & Thomas Kerr. (2022) The “goldfish bowl”: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting. Harm Reduction Journal 19:1.
Crossref
Crossref
Dennis P. Watson, Monte D. Staton & Nicole Gastala. (2022) Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Emily Pasman, Rachel Kollin, Michael Broman, Guijin Lee, Elizabeth Agius, Jamey J. Lister, Suzanne Brown & Stella M. Resko. (2022) Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Katherine A. Hirchak, Solmaz Amiri, Gordon Kordas, Oladunni Oluwoye, Abram J. Lyons, Kelsey Bajet, Judith A. Hahn, Michael G. McDonell, Aimee N. C. Campbell & Kamilla Venner. (2022) Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
Melissa N. Poulsen, Patrick B. Asdell, Wade Berrettini, Kortney McBryan & Alanna K. Rahm. (2022) Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study. SSM - Mental Health 2, pages 100151.
Crossref
Crossref
Allison R. David, Carlos R. Sian, Christina M. Gebel, Benjamin P. Linas, Jeffrey H. Samet, Linda S. Sprague Martinez, Jordana Muroff, Judith A. Bernstein & Sabrina A. Assoumou. (2022) Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study. Journal of Substance Abuse Treatment 142, pages 108870.
Crossref
Crossref
Kim A. Hoffman, Canyon Foot, Ximena A. Levander, Ryan Cook, Javier Ponce Terashima, John W. McIlveen, P. Todd Korthuis & Dennis McCarty. (2022) Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis. Journal of Substance Abuse Treatment 141, pages 108801.
Crossref
Crossref
Jayme E. Walters, Aubrey E. Jones, Aaron R. Brown & Dorothy Wallis. (2022) Impacts of the COVID-19 Pandemic on a Rural Opioid Support Services Program. International Journal of Environmental Research and Public Health 19:18, pages 11164.
Crossref
Crossref
Savitha Racha, Megan Buresh & Michael Fingerhood. (2022) Pharmacotherapy of Opioid Use Disorder—Update and Current Challenges. Psychiatric Clinics of North America 45:3, pages 335-346.
Crossref
Crossref
Em M. Pijl, Abeer Alraja, Elsie Duff, Carol Cooke, Stephen Dash, Nichole Nayak, Jesse Lamoureux, Ginette Poulin, Erin Knight & Ben Fry. (2022) Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
Elahe Naserianhanzaei & Miriam Koschate-Reis. (2022) Effects of Substance Use, Recovery, and Non–Drug-Related Online Community Participation on the Risk of a Use Episode During Remission From Opioid Use Disorder: Longitudinal Observational Study. Journal of Medical Internet Research 24:8, pages e36555.
Crossref
Crossref
Arthur Robin Williams, Christine M. Mauro, Tianshu Feng, Amanda Wilson, Angelo Cruz, Mark Olfson, Stephen Crystal, Hillary Samples & Lisa Chiodo. (2022) Non–prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder. Journal of Substance Abuse Treatment 139, pages 108770.
Crossref
Crossref
Grant Victor, Guijin Lee, Brandon del Pozo, Sydney Silverstein, Catherine Zettner, Rahni Cason & Bradley Ray. (2022) Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders. Journal of Drug Issues 52:3, pages 389-405.
Crossref
Crossref
James H. FordIIII, Aaron M. Gilson, Gina M. Bryan, Rachel E. Gicquelais, Michele Gassman & David A. Mott. (2022) Pilot testing a tool to determine the costs and time associated with community pharmacy-based administration of injectable naltrexone. Research in Social and Administrative Pharmacy 18:7, pages 3210-3215.
Crossref
Crossref
Tabor E. Flickinger, Marika Waselewski, Alexa Tabackman, Jacqueline Huynh, Jacqueline Hodges, Kori Otero, Kelly Schorling, Karen Ingersoll, Nassima Ait-Daoud Tiouririne & Rebecca Dillingham. (2022) Communication between patients, peers, and care providers through a mobile health intervention supporting medication-assisted treatment for opioid use disorder. Patient Education and Counseling 105:7, pages 2110-2115.
Crossref
Crossref
Brian Corry, Natasha Underwood, Laura J. Cremer, Cherie R. Rooks-Peck & Christopher Jones. (2022) County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019. Drug and Alcohol Dependence 236, pages 109495.
Crossref
Crossref
Nadia Abbass, Tani Malhotra, Brooke Bullington & Kavita Shah Arora. (2022) Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder. The Journal of Clinical Ethics 33:2, pages 112-123.
Crossref
Crossref
Jamey J. Lister, Guijin Lee, Jennifer D. Ellis, Emily Pasman, Elizabeth Agius & Stella M. Resko. (2022) Comorbid Affective and Substance Use Disorders of Medicaid/Medicare Beneficiaries at an Opioid Treatment Program Serving Small Urban and Rural Communities. Frontiers in Psychiatry 13.
Crossref
Crossref
A. Taylor Kelley, Marcela C. Smid, Jacob D. Baylis, Elizabeth Charron, Lori Jo Begaye, Amy Binns-Calvey, Shayla Archer, Saul Weiner, Warren Pettey & Gerald Cochran. (2022) Treatment access for opioid use disorder in pregnancy among rural and American Indian communities. Journal of Substance Abuse Treatment 136, pages 108685.
Crossref
Crossref
J. Priyanka Vakkalanka, Brian C. Lund, Marcia M. Ward, Stephan Arndt, R. William Field, Mary Charlton & Ryan M. Carnahan. (2021) Telehealth Utilization Is Associated with Lower Risk of Discontinuation of Buprenorphine: a Retrospective Cohort Study of US Veterans. Journal of General Internal Medicine 37:7, pages 1610-1618.
Crossref
Crossref
Annette S. Crisanti, Jennifer Earheart, Megan Deissinger, Kathryn Lowerre & Julie G. Salvador. (2022) Implementation Challenges and Recommendations for Employing Peer Support Workers in Emergency Departments to Support Patients Presenting after an Opioid-Related Overdose. International Journal of Environmental Research and Public Health 19:9, pages 5276.
Crossref
Crossref
Jennifer Corrigan, Willis H. Tsai, Ada Ip-Buting, Christopher Ng, Imhokhai Ogah, Peter Peller, Heather Sharpe, Cheryl Laratta & Sachin R. Pendharkar. (2022) Treatment outcomes among rural and urban patients with obstructive sleep apnea: a prospective cohort study. Journal of Clinical Sleep Medicine 18:4, pages 1013-1020.
Crossref
Crossref
Catherine Leiner, Brian Antono & Bayla Ostrach. (2022) Perinatal OUD Treatment Provider Understandings of Rural Patients’ Experiences. Journal of Addiction Medicine 16:2, pages 177-182.
Crossref
Crossref
Hannah K. Knudsen, Jeanie Hartman & Sharon L. Walsh. (2022) The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States. Drug and Alcohol Dependence 232, pages 109336.
Crossref
Crossref
Meredith C. Meacham, Alicia L. Nobles, D. Andrew Tompkins & Johannes Thrul. (2022) “I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PLOS ONE 17:2, pages e0263583.
Crossref
Crossref
Jannat SainiBreah JohnsonDanya M. Qato. (2022) Self-Reported Treatment Need and Barriers to Care for Adults With Opioid Use Disorder: The US National Survey on Drug Use and Health, 2015 to 2019. American Journal of Public Health 112:2, pages 284-295.
Crossref
Crossref
Christopher M. Jones, Debra Houry, Beth Han, Grant Baldwin, Alana Vivolo‐Kantor & Wilson M. Compton. (2021) Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Annals of the New York Academy of Sciences 1508:1, pages 3-22.
Crossref
Crossref
Sourav Khanra, Ujjwal Singh, SanjayKumar Munda & Basudeb Das. (2022) Demographic and clinical profile of women receiving inpatient treatment at a deaddiction unit of a psychiatric hospital in India: Five years' observation. Industrial Psychiatry Journal 31:1, pages 177.
Crossref
Crossref
Nathalie Huguet, Tahlia Hodes, Steffani R. Bailey, Miguel Marino, Daniel M. Hartung, Robert Voss, Jean O’Malley, Irina Chamine & John Muench. (2022) Characterizations of Opioid Prescribing in Community Health Centers in 2018. Journal of Primary Care & Community Health 13, pages 215013192210741.
Crossref
Crossref
Caitlin M. Pinciotti, Nyssa Z. Bulkes, Gregor Horvath & Bradley C. Riemann. (2022) Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic. Journal of Obsessive-Compulsive and Related Disorders 32, pages 100705.
Crossref
Crossref
Hossam Mahmoud, Emile Whaibeh & Fayth Dickenson. 2022. Essentials of Telebehavioral Health. Essentials of Telebehavioral Health
53
67
.
Jeffrey M. Rogers, Kirsten E. Smith, Justin C. Strickland & David H. Epstein. (2021) Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample. Frontiers in Pharmacology 12.
Crossref
Crossref
Ximena A. Levander, Kim A. Hoffman, John W. McIlveen, Dennis McCarty, Javier Ponce Terashima & P. Todd Korthuis. (2021) Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
A. Taylor Kelley, Marcela C. Smid, Jacob D. Baylis, Elizabeth Charron, Amy E. Binns-Calvey, Shayla Archer, Saul J. Weiner, Lori Jo Begaye & Gerald Cochran. (2021) Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
Austin E. Coye, Mackenzie T. Jones, Kasha J. Bornstein, Hansel E. Tookes & Joan E. St. Onge. (2021) A missed opportunity: underutilization of inpatient behavioral health services to reduce injection drug use sequelae in Florida. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Alison C. Lynch, Andrea N. Weber, Suzy Hedden, Sayeh Sabbagh, Stephan Arndt & Laura Acion. (2021) Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Lindy Clapp, Samuel Conner, David Fonseca, Carrie Jones, Meghan Williams & Lesly-Marie Buer. (2021) Appreciating contributions more than celebrating resilience: Reflections on the disclosure of substance use in Appalachia. International Journal of Drug Policy 98, pages 103277.
Crossref
Crossref
Elizabeth R. Hansen, Shelby Carvalho, Madelyn McDonald & Jennifer R. Havens. (2021) A qualitative examination of recent increases in methamphetamine use in a cohort of rural people who use drugs. Drug and Alcohol Dependence 229, pages 109145.
Crossref
Crossref
Elizabeth C. Saunders, Alan J. Budney, Patricia Cavazos-Rehg, Emily Scherer & Lisa A. Marsch. (2021) Comparing the feasibility of four web-based recruitment strategies to evaluate the treatment preferences of rural and urban adults who misuse non-prescribed opioids. Preventive Medicine 152, pages 106783.
Crossref
Crossref
Annabelle M. Belcher, Kelly Coble, Thomas O. Cole, Christopher J. Welsh, Anna Whitney & Eric Weintraub. (2021) Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder. Frontiers in Psychiatry 12.
Crossref
Crossref
Micah Piske, Fahmida Homayra, Jeong E. Min, Haoxuan Zhou, Carolyn Marchand, Annabel Mead, Jennifer Ng, Megan Woolner & Bohdan Nosyk. (2021) Opioid Use Disorder and Perinatal Outcomes. Pediatrics 148:4.
Crossref
Crossref
Eric Weintraub, Chamindi Seneviratne, Jessica Anane, Kelly Coble, Jessica Magidson, Sarah Kattakuzhy, Aaron Greenblatt, Christopher Welsh, Alexander Pappas, Terri L. Ross & Annabelle M. Belcher. (2021) Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder. JAMA Network Open 4:8, pages e2118487.
Crossref
Crossref
Ayaz Hyder, Jinhyung Lee, Ashley Dundon, Lauren T. Southerland, David All, Gretchen Hammond & Harvey J. Miller. (2021) Opioid Treatment Deserts: Concept development and application in a US Midwestern urban county. PLOS ONE 16:5, pages e0250324.
Crossref
Crossref
Amy M. Magnus & Patricia Advincula. (2021) Those who go without: an ethnographic analysis of the lived experiences of rural mental health and healthcare infrastructure. Journal of Rural Studies 83, pages 37-49.
Crossref
Crossref
Colleen B. Mistler, Divya K. Chandra, Michael M. Copenhaver, Jeffrey A. Wickersham & Roman Shrestha. (2020) Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals. Journal of Community Health 46:2, pages 349-357.
Crossref
Crossref
Weronika Grabowska, Selma Holden, Peter M Wayne & Karen Kilgore. (2021) An ethnographic study of opioid use disorder in rural Maine: The problem of pain. Qualitative Research in Medicine and Healthcare 4:3.
Crossref
Crossref
Sara C. Warfield, Robert P. Pack, Louisa Degenhardt, Sarah Larney, Chrianna Bharat, Lisham Ashrafioun, Brandon D.L. Marshall & Robert M. Bossarte. (2021) The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas. Journal of Substance Abuse Treatment 121, pages 108189.
Crossref
Crossref
Thomas O. Cole, Darlene Robinson, Andrea Kelley-Freeman, Devang Gandhi, Aaron D. Greenblatt, Eric Weintraub & Annabelle M. Belcher. (2021) Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment. Frontiers in Public Health 8.
Crossref
Crossref
Rebecca Stone, Julia K. Campbell, Diane Kinney & Emily F. Rothman. (2020) “He Would Take My Shoes and All the Baby's Warm Winter Gear so We Couldn't Leave”: Barriers to Safety and Recovery Experienced by a Sample of Vermont Women With Partner Violence and Opioid Use Disorder Experiences. The Journal of Rural Health 37:1, pages 35-44.
Crossref
Crossref
Orrin D. Ware, Jodi J. Frey, Marianne Cloeren, Amanda Mosby, Rachel Imboden, Alicia T. Bazell, Margo Huffman, Martin Hochheimer, Aaron D. Greenblatt & Stephan A. Sherman. (2021) Examining Employment and Employment Barriers Among a Sample of Patients in Medication-Assisted Treatment in the United States. Addictive Disorders & Their Treatment 20:4, pages 578-586.
Crossref
Crossref
R. Abadie & K. Dombrowski. (2020) “Caballo”: risk environments, drug sharing and the emergence of a hepatitis C virus epidemic among people who inject drugs in Puerto Rico. Harm Reduction Journal 17:1.
Crossref
Crossref
Paul J. Joudrey, E. Jennifer Edelman & Emily A. Wang. (2020) Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US. JAMA Psychiatry 77:11, pages 1105.
Crossref
Crossref
Paul J. Joudrey, Nicholas Chadi, Payel Roy, Kenneth L. Morford, Paxton Bach, Simeon Kimmel, Emily A. Wang & Susan L. Calcaterra. (2020) Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study. Drug and Alcohol Dependence 211, pages 107968.
Crossref
Crossref
Jamey J. Lister, Jennifer D. Ellis & Miyoung Yoon. (2020) Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013–2017. Addictive Behaviors Reports 11, pages 100234.
Crossref
Crossref